Anti–Methicillin-Resistant <i>Staphylococcus aureus</i> (MRSA) Cephalosporins Plus Daptomycin as Initial Therapy for MRSA Bacteremia: Does a “Hit Hard and Fast” Strategy Improve Outcomes?Davide Fiore Bavaro, Michele Bartoletti, Maddalena Casana et al.|Clinical Infectious Diseases|2026Cited by 1
P06. First-line combination therapy with fifth generation cephalosporins plus daptomycin compared to other-antimicrobial-regimens for methicillin-resistant <i>Staphylococcus aureus</i> bacteraemia: a multicenter retrospective cohort studyDavide Fiore Bavaro, Michele Bartoletti, Alessandra Belati et al.|JAC-Antimicrobial Resistance|2025Cited by 0
Use of Aztreonam-avibactam for infections caused by MBL-producing EnterobacteralesFilippo Medioli, Michele Bartoletti, Davide Fiore Bavaro et al.|New Microbes and New Infections|2026Cited by 0